3-mercaptopropionic acid has been researched along with Brain Vascular Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ganten, D; Lang, RE; Marin-Grez, M; Rascher, W; Unger, T; Yukimura, T | 1 |
1 other study(ies) available for 3-mercaptopropionic acid and Brain Vascular Disorders
| Article | Year |
|---|---|
SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
Topics: 3-Mercaptopropionic Acid; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cerebrovascular Disorders; Hypertension; Kallikreins; Male; Natriuresis; Potassium; Proline; Rats; Renin; Sulfhydryl Compounds; Thiazolidines | 1982 |